Meu SciELO
Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Citado por Google
Similares em SciELO
Similares em Google
Compartilhar
Revista de la Sociedad Española del Dolor
versão impressa ISSN 1134-8046
Resumo
ORTS-JORQUERA, B; MURIEL-SERRANO, J e PEIRO-PEIRO, AM. Pharmacogenetics in analgesic response: towards a sex-differences personalized medicine. Rev. Soc. Esp. Dolor [online]. 2023, vol.30, n.2, pp.115-124. Epub 05-Fev-2024. ISSN 1134-8046. https://dx.doi.org/10.20986/resed.2023.4042/2022.
Chronic pain is a silent epidemic, affecting 1 in 5 adults in Europe. This fact coexists with the abuse of analgesic drugs by some patients, a circumstance that is limiting their prescription in chronic non-cancer pain. The challenge would be to be able to select the people who, a priori, would have a better analgesic response based on a series of intrinsic conditions. This review analyzes the differences based on sex and the presence of certain variants in the genes that encode the mu opioid receptor (OPRM1), the cytochrome metabolizing enzyme CYP2D6 and the catechol-O-methyltransferase (COMT) that degrades catecholamines. The objective is to provide potentially explanatory elements that can guide the clinical professional in the selection of a more personalized analgesia.
Palavras-chave : Chronic pain; pharmacogenetics; OPRM1; CYP2D6; sex-differences.